Patents by Inventor Edvar Onsoyen

Edvar Onsoyen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7776839
    Abstract: A pharmaceutical composition is provided for use in the healing of cells containing about 0.0001 percent weight per volume (% w/v) to about 2% w/v of an alginic acid or a salt of alginic acid having a molecular weight in the range of greater than about 250,000 to about 1,000,000, provided that if the composition additionally contains an alginic acid or a salt of alginic acid having a molecular weight in the range of about 20,000 to about 250,000, it is present in an amount of less than 1% w/w. The use of the pharmaceutical composition for the healing cells in a mammal, preferably mucosal cells is also provided.
    Type: Grant
    Filed: September 10, 2002
    Date of Patent: August 17, 2010
    Assignee: Reckitt Benckiser Healthcare (UK) Limited
    Inventors: Raffaele Del Buono, Peter William Dettmar, Frank Chadwick Hampson, Ian Gordon Jolliffe, Paul Murray McPherson, Edvar Onsoyen, Massimo Pignatelli, Peter Edward Ross
  • Publication number: 20060159823
    Abstract: Kits and compositions for producing an alginate gel are disclosed. The kits and compositions comprise soluble alginate and insoluble alginate/gelling ion particles. Methods for dispensing a self-gelling alginate dispersion are disclosed. The methods comprise forming a dispersion of insoluble alginate/gelling ion particles in a solution containing soluble alginate, and dispensing the dispersion whereby the dispersion forms an alginate gel matrix. The methods may include dispensing the dispersion into the body of an individual. An alginate gel having a thickness of greater than 5 mm and a homogenous alginate matrix network and homogenous alginate gels free of one or more of: sulfates citrates, phosphates, lactatates, EDTA or lipids are disclosed. Implantable devices comprising a homogenous alginate gel coating are disclosed. Methods of improving the viability of pancreatic islets, or other cellular aggregates or tissue, following isolation and during storage and transport are disclosed.
    Type: Application
    Filed: October 12, 2005
    Publication date: July 20, 2006
    Inventors: Jan-Egil Melvik, Michael Dornish, Edvar Onsoyen, Astrid Berge, Terje Svendsen
  • Publication number: 20030130229
    Abstract: A pharmaceutical composition is provided for use in the healing of cells containing about 0.0001 percent weight per volume (% w/v) to about 2% w/v of an alginic acid or a salt of alginic acid having a molecular weight in the range of greater than about 250,000 to about 1,000,000, provided that if the composition additionally contains an alginic acid or a salt of alginic acid having a molecular weight in the range of about 20,000 to about 250,000, it is present in an amount of less than 1% w/w. The use of the pharmaceutical composition for the healing cells in a mammal, preferably mucosal cells is also provided.
    Type: Application
    Filed: September 10, 2002
    Publication date: July 10, 2003
    Applicant: Reckitt Benckiser Healthcare (UK) Limited
    Inventors: Raffaele Del Buono, Peter William Dettmar, Frank Chadwick Hampson, Ian Gordon Jolliffe, Paul Murray McPherson, Edvar Onsoyen, Massimo Pignatelli, Peter Edward Ross
  • Patent number: 6407226
    Abstract: The use of G-block polysaccharides as a modulator for the rheology in a mixture in which a gelling, water-soluble polysaccharide is a component to give the final product a changed viscosity, stability, elasticity, rigidity or similar.
    Type: Grant
    Filed: July 11, 1997
    Date of Patent: June 18, 2002
    Assignee: FMC Biopolymer AS
    Inventors: Merethe Kamfjord Simensen, Edvar Onsøyen, Kurt Ingar Draget, Olav Smidsrød, Therese Fjæreide